Biotech · Private company
Alkeus Pharmaceuticals, Inc.
Track this companyFree. Adds Alkeus Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ALK-001Phase 3 · Stargardt DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ALK-001 oral capsulePhase 3 · Geographic AtrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of ALK-001 on the Progression of Stargardt DiseasePHASE3 · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07419334 · fetched Nov 12, 2026
- Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 20, 2019ClinicalTrials.gov NCT04239625 · fetched Nov 12, 2026
- Phase 2/3 Study of ALK-001 in Geographic AtrophyPHASE2_PHASE3 · COMPLETED · started May 7, 2019ClinicalTrials.gov NCT03845582 · fetched Nov 12, 2026
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Aug 1, 2015ClinicalTrials.gov NCT02402660 · fetched Nov 12, 2026